Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
The Lancet, ISSN: 0140-6736, Vol: 379, Issue: 9826, Page: 1613-1620
2012
- 535Citations
- 355Captures
- 5Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations535
- Citation Indexes522
- 522
- CrossRef504
- Policy Citations10
- Policy Citation10
- Clinical Citations3
- PubMed Guidelines3
- Captures355
- Readers355
- 355
- Mentions5
- References3
- Wikipedia3
- Blog Mentions1
- Blog1
- News Mentions1
- News1
Most Recent News
Early corticosteroid therapy associated with better outcomes in Kawasaki Disease
1. In this meta-analysis of available comparative studies, use of corticosteroids as adjunctive therapy to IVIG and aspirin in Kawasaki disease was associated with a lower risk of coronary artery abnormality and earlier defervescence compared to IVIG/ASA alone. 2. In subgroup analysis the earlier timing of steroid therapy had lower risk of coronary artery abnormality
Article Description
Evidence indicates that corticosteroid therapy might be beneficial for the primary treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to intravenous immunoglobulin with aspirin would reduce the incidence of coronary artery abnormalities in patients with severe Kawasaki disease.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0140673611619302; http://dx.doi.org/10.1016/s0140-6736(11)61930-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862797088&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22405251; https://linkinghub.elsevier.com/retrieve/pii/S0140673611619302; http://linkinghub.elsevier.com/retrieve/pii/S0140673611619302; http://api.elsevier.com/content/article/PII:S0140673611619302?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0140673611619302?httpAccept=text/plain; http://f1000.com/717956630#eval793461248; http://dx.doi.org/10.3410/f.717956630.793461248
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know